Cargando…

The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes

The aim of this study was to analyze the relationship between immunological markers and the dysfunction of cutaneous microcirculation in young patients with type 1 diabetes. The study group consisted of 46 young patients with type 1 diabetes and no associated complications. Microvascular function wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Neubauer-Geryk, Jolanta, Wielicka, Melanie, Myśliwiec, Małgorzata, Zorena, Katarzyna, Bieniaszewski, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604652/
https://www.ncbi.nlm.nih.gov/pubmed/37893230
http://dx.doi.org/10.3390/biomedicines11102857
_version_ 1785126886024675328
author Neubauer-Geryk, Jolanta
Wielicka, Melanie
Myśliwiec, Małgorzata
Zorena, Katarzyna
Bieniaszewski, Leszek
author_facet Neubauer-Geryk, Jolanta
Wielicka, Melanie
Myśliwiec, Małgorzata
Zorena, Katarzyna
Bieniaszewski, Leszek
author_sort Neubauer-Geryk, Jolanta
collection PubMed
description The aim of this study was to analyze the relationship between immunological markers and the dysfunction of cutaneous microcirculation in young patients with type 1 diabetes. The study group consisted of 46 young patients with type 1 diabetes and no associated complications. Microvascular function was assessed with the use of nail fold capillaroscopy before and after implementing post-occlusive reactive hyperemia. This evaluation was then repeated after 12 months. Patients were divided into two subgroups according to their baseline median coverage (defined as the ratio of capillary surface area to surface area of the image area), which was established during the initial exam (coverage(BASE)). Additionally, the levels of several serum biomarkers, including VEGF, TNF-a and IL-35, were assessed at the time of the initial examination. HbA1c levels obtained at baseline and after a 12-month interval were also obtained. Mean HbA1c levels obtained during the first two years of the course of the disease were also analyzed. Patients with coverage(BASE) below 16.85% were found to have higher levels of VEGF and TNF-α, as well as higher levels of HbA1c during the first two years following diabetes diagnosis. Our results support the hypothesis that the development of diabetic complications is strongly influenced by metabolic memory and an imbalance of pro- and anti-inflammatory cytokines, regardless of achieving adequate glycemic control.
format Online
Article
Text
id pubmed-10604652
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106046522023-10-28 The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes Neubauer-Geryk, Jolanta Wielicka, Melanie Myśliwiec, Małgorzata Zorena, Katarzyna Bieniaszewski, Leszek Biomedicines Article The aim of this study was to analyze the relationship between immunological markers and the dysfunction of cutaneous microcirculation in young patients with type 1 diabetes. The study group consisted of 46 young patients with type 1 diabetes and no associated complications. Microvascular function was assessed with the use of nail fold capillaroscopy before and after implementing post-occlusive reactive hyperemia. This evaluation was then repeated after 12 months. Patients were divided into two subgroups according to their baseline median coverage (defined as the ratio of capillary surface area to surface area of the image area), which was established during the initial exam (coverage(BASE)). Additionally, the levels of several serum biomarkers, including VEGF, TNF-a and IL-35, were assessed at the time of the initial examination. HbA1c levels obtained at baseline and after a 12-month interval were also obtained. Mean HbA1c levels obtained during the first two years of the course of the disease were also analyzed. Patients with coverage(BASE) below 16.85% were found to have higher levels of VEGF and TNF-α, as well as higher levels of HbA1c during the first two years following diabetes diagnosis. Our results support the hypothesis that the development of diabetic complications is strongly influenced by metabolic memory and an imbalance of pro- and anti-inflammatory cytokines, regardless of achieving adequate glycemic control. MDPI 2023-10-22 /pmc/articles/PMC10604652/ /pubmed/37893230 http://dx.doi.org/10.3390/biomedicines11102857 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Neubauer-Geryk, Jolanta
Wielicka, Melanie
Myśliwiec, Małgorzata
Zorena, Katarzyna
Bieniaszewski, Leszek
The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes
title The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes
title_full The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes
title_fullStr The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes
title_full_unstemmed The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes
title_short The Relationship between TNF-a, IL-35, VEGF and Cutaneous Microvascular Dysfunction in Young Patients with Uncomplicated Type 1 Diabetes
title_sort relationship between tnf-a, il-35, vegf and cutaneous microvascular dysfunction in young patients with uncomplicated type 1 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604652/
https://www.ncbi.nlm.nih.gov/pubmed/37893230
http://dx.doi.org/10.3390/biomedicines11102857
work_keys_str_mv AT neubauergerykjolanta therelationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT wielickamelanie therelationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT mysliwiecmałgorzata therelationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT zorenakatarzyna therelationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT bieniaszewskileszek therelationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT neubauergerykjolanta relationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT wielickamelanie relationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT mysliwiecmałgorzata relationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT zorenakatarzyna relationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes
AT bieniaszewskileszek relationshipbetweentnfail35vegfandcutaneousmicrovasculardysfunctioninyoungpatientswithuncomplicatedtype1diabetes